Diabetic Gastroparesis Global Clinical Trials Review, H1, 2015

Diabetic Gastroparesis Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2673CTIDB
  • |
  • Pages: 74
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Diabetic Gastroparesis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Diabetic Gastroparesis Global Clinical Trials Review, H1, 2015" provides data on the Diabetic Gastroparesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Gastroparesis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Gastroparesis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Diabetic Gastroparesis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by G7 Countries: Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials 17

Clinical Trials by Phase 18

In Progress Trials by Phase 19

Clinical Trials by Trial Status 20

Clinical Trials by End Point Status 21

Unaccomplished Trials of Diabetic Gastroparesis 22

Subjects Recruited Over a Period of Time 24

Clinical Trials by Sponsor Type 25

Prominent Sponsors 26

Top Companies Participating in Diabetic Gastroparesis Therapeutics Clinical Trials 27

Prominent Drugs 28

Latest Clinical Trials News on Diabetic Gastroparesis 29

Apr 16, 2015: Targacept Announces Negative Top-Line Results from Exploratory Study of TC-6499 in Diabetic Gastroparesis 29

Apr 08, 2015: Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis 29

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

Evoke Pharma, Inc. 31

Clinical Trial Overview of Evoke Pharma, Inc. 31

Rhythm Pharmaceuticals 32

Clinical Trial Overview of Rhythm Pharmaceuticals 32

Ocera Therapeutics, Inc. 33

Clinical Trial Overview of Ocera Therapeutics, Inc. 33

Ironwood Pharmaceuticals, Inc. 34

Clinical Trial Overview of Ironwood Pharmaceuticals, Inc. 34

Theravance, Inc. 35

Clinical Trial Overview of Theravance, Inc. 35

Targacept, Inc. 36

Clinical Trial Overview of Targacept, Inc. 36

GlaxoSmithKline plc 37

Clinical Trial Overview of GlaxoSmithKline plc 37

Alfa Wassermann S.p.A 38

Clinical Trial Overview of Alfa Wassermann S.p.A 38

Chong Kun Dang Pharmaceutical Corp. 39

Clinical Trial Overview of Chong Kun Dang Pharmaceutical Corp. 39

Axis Clinical Trials 40

Clinical Trial Overview of Axis Clinical Trials 40

Clinical Trial Overview of Top Institutes / Government 41

Dartmouth-Hitchcock Medical Center 41

Clinical Trial Overview of Dartmouth-Hitchcock Medical Center 41

Duke University Medical Center 42

Clinical Trial Overview of Duke University Medical Center 42

Malmo University Hospital 43

Clinical Trial Overview of Malmo University Hospital 43

Qingdao University 44

Clinical Trial Overview of Qingdao University 44

Rabin Medical Center 45

Clinical Trial Overview of Rabin Medical Center 45

University of Calgary 46

Clinical Trial Overview of University of Calgary 46

Vienna General Hospital 47

Clinical Trial Overview of Vienna General Hospital 47

Yokohama City University 48

Clinical Trial Overview of Yokohama City University 48

Five Key Clinical Profiles 49

Appendix 72

Abbreviations 72

Definitions 72

Research Methodology 73

Secondary Research 73

About GlobalData 74

Contact Us 74

Disclaimer 74

Source 74

List of Figures

Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Diabetic Gastroparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Diabetic Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Diabetic Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Diabetic Gastroparesis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 14

Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 17

Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18

Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19

Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24

Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28

GlobalData Methodology 73

List of Tables

Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Diabetic Gastroparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Diabetic Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Diabetic Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Diabetic Gastroparesis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Diabetic Gastroparesis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 14

Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 17

Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Phase, 2015* 18

Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19

Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21

Diabetic Gastroparesis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 22

Diabetic Gastroparesis Therapeutics, Global, Terminated Clinical Trials, 2015* 23

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24

Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Evoke Pharma, Inc., 2015* 31

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rhythm Pharmaceuticals, 2015* 32

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ocera Therapeutics, Inc., 2015* 33

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ironwood Pharmaceuticals, Inc., 2015* 34

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Theravance, Inc., 2015* 35

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Targacept, Inc., 2015* 36

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 37

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfa Wassermann S.p.A, 2015* 38

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chong Kun Dang Pharmaceutical Corp., 2015* 39

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Axis Clinical Trials, 2015* 40

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dartmouth-Hitchcock Medical Center, 2015* 41

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University Medical Center, 2015* 42

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Malmo University Hospital, 2015* 43

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Qingdao University, 2015* 44

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2015* 45

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2015* 46

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Vienna General Hospital, 2015* 47

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2015* 48

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Evoke Pharma, Inc.

Rhythm Pharmaceuticals

Ocera Therapeutics, Inc.

Ironwood Pharmaceuticals, Inc.

Theravance, Inc.

Targacept, Inc.

GlaxoSmithKline plc

Alfa Wassermann S.p.A

Chong Kun Dang Pharmaceutical Corp

Axis Clinical Trials

Diabetic Gastroparesis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Diabetic Gastroparesis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 160650
Site License
USD 5000 INR 321300
Corporate User License
USD 7500 INR 481950

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com